JG
TARA icon

Jain Global’s Protara Therapeutics TARA Stock Holding History

Jain Global’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.2K Buy
+21,000
New +$99.9K ﹤0.01% 1638
2025
Q2 		– Sell
-19,212
Closed -$81.8K – 1601
2025
Q1 		$81.8K Buy
+19,212
New +$85.8K ﹤0.01% 979

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Jain Global's TARA Position: Q2 2026 in Review

Jain Global opened a new position in Protara Therapeutics (TARA) in Q2 2026: 21,000 shares worth $80.2K. The stake represents ﹤0.01% of the portfolio and ranks #1638 among its holdings. This is a return to the name: Jain Global previously reported a position in TARA as recently as Q1 2025.

Jain Global first reported a position in TARA in Q1 2025 and has held it in 2 quarters since. The position peaked at $81.8K in Q1 2025. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Jain Global held 21,000 shares of Protara Therapeutics worth $80.2K as of Q2 2026.
  • Protara Therapeutics was a new Jain Global position in Q2 2026.
  • Protara Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1638 holding.
  • Jain Global first reported a position in Protara Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • Jain Global's Protara Therapeutics position peaked at $81.8K in Q1 2025.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.